Effectiveness and costs of atypical versus typical antipsychotic treatment for schizophrenia in routine care

被引:0
作者
Stargardt, T.
Weinbrenner, S.
Busse, R.
Juckel, G.
Gericke, C. A.
机构
[1] Berlin Univ Technol, Berlin, Germany
[2] Ruhr Univ Bochum, Sch Med, D-4630 Bochum, Germany
[3] Univ Adelaide, Adelaide, SA, Australia
关键词
D O I
10.1016/S1098-3015(10)63183-X
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A196 / A196
页数:1
相关论文
共 50 条
[1]   Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care [J].
Stargardt, Tom ;
Weinbrenner, Susanne ;
Busse, Reinhard ;
Juckel, Georg ;
Gericke, Christian A. .
JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2008, 11 (02) :89-97
[2]   Effectiveness and Cost of Atypical Versus Typical Antipsychotic Treatment in a Nationwide Cohort of Patients With Schizophrenia in Germany [J].
Stargardt, Tom ;
Edel, Marc-Andreas ;
Ebert, Andreas ;
Busse, Reinhard ;
Juckel, Georg ;
Gericke, Christian A. .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (05) :602-607
[3]   The effectiveness of the atypical antipsychotic aripiprazole versus standard of care treatment in patients with schizophrenia: The star study [J].
Kerwin, R. ;
L'Italien, G. ;
Hanssens, L. ;
Marcus, R. N. ;
McQuade, R. ;
Carson, W. H. ;
Bewen, J. -N. .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 :S283-S283
[4]   Prevalence of hyperprolactinemia in schizophrenia: Association with typical and atypical antipsychotic treatment [J].
Montgomery, J ;
Winterbottom, E ;
Jessani, M ;
Kohegyi, E ;
Fulmer, J ;
Seamonds, B ;
Josiassen, RC .
JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (11) :1491-1498
[5]   Atypical versus typical antipsychotic treatment prognosis based on VEPs and WCST scores in paranoid schizophrenia [J].
Mazurek, I ;
Loza, B ;
Lecyk, A .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 :S347-S348
[6]   Typical and atypical antipsychotic use and relapses in schizophrenia [J].
Cáceres, M. C. ;
Peñas-Lledó, E. M. ;
Dorado, P. ;
de la Rubia, A. ;
González, I. ;
Gutierrez, J. R. ;
LLerena, A. .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 99 :34-35
[7]   Safety and effectiveness of olanzapine versus typical antipsychotic drugs in the treatment of inpatients with schizophrenia (EUROPA study) [J].
Gomez, JC ;
Sacristan, JA ;
Carrasco, PR ;
Alvarez, E ;
Bobes, J ;
Cañas, F ;
Gascon, J ;
Gibert, J ;
Gutierrez, M .
EUROPEAN PSYCHIATRY, 2000, 15 :409S-409S
[8]   Hormonal side effects in women: Typical versus atypical antipsychotic treatment [J].
Dickson, RA ;
Seeman, MV ;
Corenblum, B .
JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 :10-15
[9]   Effectiveness and onset of action of olanzapine versus typical antipsychotic drugs in the treatment of inpatients with schizophrenia (Europa study) [J].
Alvarez, E ;
Gómez, J ;
Sacristan, JA ;
Bobes, J ;
Cañas, F ;
Carrasco, JL ;
Gascón, J .
SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) :219-219
[10]   Onset of action and effectiveness with olanzapine versus typical antipsychotic drugs in the treatment of inpatients with schizophrenia (EUROPA Study) [J].
Gutierrez, M ;
Ciudad, A ;
Alvarez, E ;
Bobes, J ;
Cañas, F ;
Carrasco, JL ;
Gascon, J ;
Gibert, J ;
Gómez, JC .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 :S52-S52